Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Aerosolized red-tide toxins (brevetoxins) and asthma.
|
Chest
|
2007
|
2.70
|
2
|
The porcine lung as a potential model for cystic fibrosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2008
|
2.53
|
3
|
Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor.
|
Crit Care Med
|
2009
|
1.41
|
4
|
Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation.
|
Clin Exp Pharmacol Physiol
|
2009
|
1.39
|
5
|
Review of Florida Red Tide and Human Health Effects.
|
Harmful Algae
|
2011
|
1.12
|
6
|
Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease.
|
J Pharmacol Exp Ther
|
2008
|
1.11
|
7
|
Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
|
J Pharmacol Exp Ther
|
2004
|
1.05
|
8
|
Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib.
|
J Med Chem
|
2008
|
1.03
|
9
|
Exposure and effect assessment of aerosolized red tide toxins (brevetoxins) and asthma.
|
Environ Health Perspect
|
2009
|
1.00
|
10
|
Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
|
J Med Chem
|
2003
|
0.96
|
11
|
Receptor-mediated enhancement of beta adrenergic drug activity by ascorbate in vitro and in vivo.
|
PLoS One
|
2010
|
0.95
|
12
|
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524).
|
J Med Chem
|
2007
|
0.95
|
13
|
An Epidemiologic Approach to the Study of Aerosolized Florida Red Tides.
|
Harmful Algae 2002 (2002)
|
1
|
0.94
|
14
|
Tryptase: potential role in airway inflammation and remodeling.
|
Am J Physiol Lung Cell Mol Physiol
|
2002
|
0.94
|
15
|
Efficacy of IL-13 neutralization in a sheep model of experimental asthma.
|
Am J Respir Cell Mol Biol
|
2006
|
0.93
|
16
|
Synthesis, modeling, and biological evaluation of analogues of the semisynthetic brevetoxin antagonist beta-naphthoyl-brevetoxin.
|
Chembiochem
|
2007
|
0.93
|
17
|
Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation.
|
Am J Respir Crit Care Med
|
2009
|
0.92
|
18
|
Hyaluronan blocks human neutrophil elastase (HNE)-induced airway responses in sheep.
|
Pulm Pharmacol Ther
|
2003
|
0.91
|
19
|
Characterization of tamulamides A and B, polyethers isolated from the marine dinoflagellate Karenia brevis.
|
J Nat Prod
|
2010
|
0.91
|
20
|
Therapeutic targeting of endothelial ligands for L-selectin (PNAd) in a sheep model of asthma.
|
Am J Pathol
|
2005
|
0.88
|
21
|
Na+/H+ exchange inhibition delays the onset of hypovolemic circulatory shock in pigs.
|
Shock
|
2008
|
0.87
|
22
|
Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
|
Am J Respir Cell Mol Biol
|
2013
|
0.86
|
23
|
Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion.
|
Am J Physiol Lung Cell Mol Physiol
|
2013
|
0.85
|
24
|
Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2alpha: optimization of in vitro potency and rat pharmacokinetics for oral efficacy.
|
Bioorg Med Chem
|
2007
|
0.85
|
25
|
Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep.
|
Chest
|
2005
|
0.85
|
26
|
Aerosolized Red Tide Toxins (Brevetoxins) and Asthma: Continued health effects after 1 hour beach exposure.
|
Harmful Algae
|
2011
|
0.84
|
27
|
Leukocytic cell sources of airway tissue kallikrein.
|
Am J Physiol Lung Cell Mol Physiol
|
2003
|
0.84
|
28
|
Recombinant alpha 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep.
|
J Appl Physiol (1985)
|
2002
|
0.84
|
29
|
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma.
|
J Pharmacol Exp Ther
|
2011
|
0.83
|
30
|
Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs.
|
PLoS One
|
2013
|
0.83
|
31
|
Identification of potent and novel alpha4beta1 antagonists using in silico screening.
|
J Med Chem
|
2002
|
0.82
|
32
|
Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
|
Mol Pharmacol
|
2010
|
0.82
|
33
|
Montelukast prevents antigen-induced mucociliary dysfunction in sheep.
|
Am J Respir Crit Care Med
|
2002
|
0.80
|
34
|
Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep.
|
J Appl Physiol (1985)
|
2007
|
0.80
|
35
|
Effect of oral and intravenous heparin tetrasaccharide on allergic airway responses: critical role of N-sulfation.
|
Pulm Pharmacol Ther
|
2012
|
0.80
|
36
|
NHE1 inhibition improves tissue perfusion and resuscitation outcome after severe hemorrhage.
|
J Surg Res
|
2012
|
0.80
|
37
|
Repeated exposure to aerosolized brevetoxin-3 induces prolonged airway hyperresponsiveness and lung inflammation in sheep.
|
Inhal Toxicol
|
2011
|
0.79
|
38
|
Florida Red Tide Toxins (Brevetoxins) and Longitudinal Respiratory Effects in Asthmatics.
|
Harmful Algae
|
2011
|
0.79
|
39
|
Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases.
|
Biochem J
|
2009
|
0.79
|
40
|
Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives.
|
Bioorg Med Chem Lett
|
2008
|
0.78
|
41
|
Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agent.
|
Bioorg Med Chem
|
2006
|
0.77
|
42
|
Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence.
|
Respir Res
|
2012
|
0.77
|
43
|
Aza-bicyclic amino acid sulfonamides as alpha(4)beta(1)/alpha(4)beta(7) integrin antagonists.
|
Bioorg Med Chem Lett
|
2004
|
0.75
|